Much progress has been made on many health front, including malaria, tuberculosis, and the 17 neglected tropical diseases (NTDs) since the launch of the Millennium Development Goals in 2000. Yet many diseases remain—and many new ones are emerging—as significant challenges to public health and economic in both developing and developed countries alike. The realization that much of the neglected disease burden is found among the poor who live in wealthier G20 countries plus Nigeria, a notion termed Blue Marble Health1 coined by Peter Hotez, should spur the urgency for these nations to provide significantly increased financial support to solve these challenges.
Yes, there have been reductions in the global prevalence and disease burden of neglected diseases, but efforts have stalled and new urgencies have remained unfunded2. Most importantly, many national healthcare infrastructures cannot cope with emergencies, internal migrations, war, urbanization, deforestation, and other social forces and the world remains as unprepared as it was during the recent West African Ebola virus outbreak.
1 Hotez PJ 2015. Blue Marble Health Redux: Neglected Tropical Diseases and Human Development in the Group of 20 (G20) Nations and Nigeria. PLoS Negl Trop Dis 9(7): e0003672. [http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0003672]
2 The Lancet 2015. Nov 28;386(10009):2145-91. doi: 10.1016/S0140-6736(15)61340-X. Epub 2015 Aug 28. [https://www.ncbi.nlm.nih.gov/pubmed/26321261]